Description
BLI850 is a bowel preparation agent specifically formulated for cleansing the colon prior to colonoscopy procedures. Based on clinical trial data, this compound serves as a preparatory medication to ensure adequate visualization during colonoscopic screening and surveillance procedures commonly performed in colorectal cancer patients. The agent appears to be in late-stage development as an alternative to currently available bowel preparation solutions.
Mechanism of Action
BLI850 functions as an osmotic laxative that draws water into the intestinal lumen, promoting rapid and thorough evacuation of bowel contents. The specific formulation likely contains polyethylene glycol or similar osmotic agents that increase fluid retention in the colon, facilitating complete cleansing of the bowel wall for optimal endoscopic visualization.
Side Effects
Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.
Clinical Trials
Quick Info
| Brand Name | Not yet branded |
| Category | Other Medications |
 Status | Experimental |
| Administration | Oral |
| Clinical Trials | 2 |
Related Medications
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.